MarketPulse — Real-Time Financial News & Market Analysis

Verisk Analytics raises $1 billion through dual-tranche senior notes offering to refinance existing borrowings and optimize its debt structure.

Salesforce shows strong AI growth and cash flow, but high valuation multiples and elevated stock compensation amid slowing revenue growth raise shareholder value concerns.

DME Capital trimmed Victoria's Secret holdings amid 93% rally, citing valuation concerns despite strong fundamentals and ongoing momentum.

Elliott Management and Starboard Value acquire major stakes in Norwegian Cruise Line and TripAdvisor respectively, pushing for operational improvements and strategic changes in travel sector.

Viking Therapeutics advances obesity drug VK2735 into Phase 3 trials after positive interim results, positioning itself in the competitive weight-loss pharmaceutical market.

Domino's stock jumped 4.09% on strong fiscal 2025 results: 776 new stores, 3.7% same-store sales growth, and 9.4% EPS increase. Company raised dividend 15%.

Western Union offers 10% dividend yield, attracting income investors despite fintech competition and declining stock performance. Sustainability depends on successful digital transformation.

Law firm investigates Alvotech after FDA rejected applications following failed facility inspection, causing stock to plunge 34%. Investors sought for potential securities litigation.

Navan faces securities fraud lawsuit over IPO disclosure gaps regarding undisclosed sales expenses and slowing revenue growth. Stock fell 48% since offering.

TPL stock rose on analyst upgrade recognizing power generation opportunity. KeyBanc raised price target to $639, citing AI data center infrastructure potential on Permian Basin lands.

Class action investigations launched against Ramaco Resources and Beyond Meat for alleged securities violations. Investors face deadlines of March 31 and March 24, 2026, respectively, to petition as lead plaintiffs.

Class action lawsuit filed against Navan alleging IPO disclosure failures on sales and marketing costs. Stock fell 64% from $25 to $9.01 since offering.

Tesla's robotaxi fleet shows crash rates 4-8 times higher than human drivers, with only 42 vehicles operating. Regulatory challenges and high stock valuations intensify pressure on autonomous ambitions.

Alight shares plummeted after BofA downgraded the stock, citing weak Q4 earnings and cautious 2026 guidance. Revenue projections and retention metrics disappointed investors.

Tesla slashes Cybertruck price to $59,990 for 10 days to gauge demand amid a 49% sales decline, using response to set permanent pricing strategy.

Corcept Therapeutics faces class action lawsuit for allegedly misleading statements about relacorilant's clinical evidence. FDA rejected the drug application, causing stock to plummet 50%.

Ostin Technology faces class action lawsuit alleging securities fraud scheme involving fraudulent offerings and stock price manipulation that netted $110 million before collapsing 94%.

Opendoor accelerated inventory turnover, purchasing 46% more homes sequentially while cutting extended-stay inventory from 51% to 33%, signaling improved operational efficiency and profitability.

Supernus Pharmaceuticals will present at three major healthcare conferences in March 2026, updating investors on strategic initiatives and operational progress.

Nvidia's valuation hits 12-month low at 24x forward earnings. Historical patterns suggest potential upside, though $4.6 trillion market cap may limit gains despite strong fundamentals.